Oscar Health (NYSE:OSCR) Stock Price Down 5.2% – Time to Sell?

Oscar Health, Inc. (NYSE:OSCR) shares were down 5.2% on Friday . The company traded as low as $16.03 and last traded at $16.31. Approximately 458,559 shares were traded during mid-day trading, a decline of 86% from the average daily volume of 3,191,652 shares. The stock had previously closed at $17.20.

Analyst Ratings Changes

Several analysts recently commented on OSCR shares. Piper Sandler reaffirmed an “overweight” rating and set a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. UBS Group initiated coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective on the stock. Three equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $24.00.

Oscar Health Price Performance

The business has a fifty day simple moving average of $18.86 and a 200-day simple moving average of $18.31. The stock has a market capitalization of $3.94 billion, a P/E ratio of -125.45, a PEG ratio of 31.76 and a beta of 1.62. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.91.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The company had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.13 billion. During the same period last year, the business posted ($0.07) earnings per share. Oscar Health’s revenue was up 44.6% on a year-over-year basis. Sell-side analysts expect that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.

Insider Activity at Oscar Health

In other news, CFO Richard Scott Blackley sold 68,978 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $1,240,914.22. Following the sale, the chief financial officer now directly owns 884,213 shares in the company, valued at $15,906,991.87. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. In other Oscar Health news, CFO Richard Scott Blackley sold 68,978 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $1,240,914.22. Following the completion of the sale, the chief financial officer now owns 884,213 shares of the company’s stock, valued at $15,906,991.87. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Victoria Baltrus sold 4,226 shares of Oscar Health stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $76,025.74. Following the completion of the transaction, the chief accounting officer now owns 140,648 shares in the company, valued at approximately $2,530,257.52. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 169,569 shares of company stock worth $3,007,069. 25.11% of the stock is owned by company insiders.

Institutional Trading of Oscar Health

Institutional investors have recently made changes to their positions in the stock. Avalon Trust Co bought a new position in Oscar Health in the first quarter worth about $69,000. Point72 Hong Kong Ltd bought a new stake in shares of Oscar Health during the second quarter valued at approximately $78,000. Quest Partners LLC purchased a new stake in Oscar Health in the second quarter worth $93,000. Amalgamated Bank raised its holdings in Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after purchasing an additional 1,458 shares in the last quarter. Finally, Optimum Investment Advisors purchased a new position in Oscar Health during the third quarter valued at $142,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.